Tarazona said that Peru has no manufacturing plant or logistics necessary for a full-scale vaccine production, so he asserted that the release of patents, if effective, will have too little impact on his country.

‘It would be easier for us to access vaccines from nearby countries when they are needed,’ he added.

Peru acquired or has a commitment to purchase 60 million Covid-19 vaccine doses from several nations and is considering more purchases due to the possibility that it may be necessary to be vaccinated periodically.

ef/pll/jf/mrs